New YorkAnd London, August 11, 2022 /prnewswire/- Huma Therapeutics LimitedA leading global digital health company, has appointed Kaushik Gune as the company’s new US Head of Healthcare. Gune meets Huma To further commercial adoption of the company’s digital health platforms in the US, in particular its ‘home care’ Platform for remote patient monitoring.
Gunay said, “Huma is transforming healthcare and research with its digital-first patient care platform, increasing patient access, enhancing clinical staff capacity, and providing data insights for researchers and providers. ” “I am proud to join a team committed to transforming healthcare for all.”
“Huma has established a strong track record working with over 27 million patients on its platform in the UK and around the world Europe – in both primary and secondary care,” said Michael McDonnellSVP Healthcare and Global Head of Operations, Huma Therapeutics, On the basis of digital health partnership with Huma astraZenecaas well as prestigious prix galleon Awards, we are now continuing our mission of providing digital-first care and research to the US market. Kaushik is the perfect leader for our expansion, combining strategic insights with the business insights needed to bring our remote monitoring technology to millions of Americans.”
Gunn has held several senior leadership roles during his career with a focus on developing and advancing commercial products in the digital health market, most recently as VP of Digital Health & New Ventures at Smith + Nephew. Prior to this, he served as Chief Strategy and Business Development Officer at Innovative Health Diagnostics, where he led a clinical laboratory through a key growth phase managing finance, strategy and business development functions.
From a career spanning multiple business functions, Gunn brings experience from operations at United Airlines, strategy at McKinsey & Company, and finance at Commercial and Nuvasive. He has done BE in Mechanical Engineering from the university MumbaiMS in Industrial Engineering from Purdue University and an MBA in Strategy and Finance from INSEAD.
about Huma
Huma Therapeutics is a global digital health company headquartered in the UK that advances digital-first care delivery and research to help people live longer, fuller lives. Huma’s award-winning modular platform is used by over 3,000 hospitals and clinics, with 1.8 million active users. Huma’s offering works in various disease areas and strengths:
– ‘Hospital at home’
– Software as a Medical Device (SAMD) solution
– DCT platform to support digital or hybrid studies
Huma’s platform has nearly doubled clinical capacity, reduced readmissions by more than a third, enabled better diversity, participant retention and protocol adherence, while allowing trials to run within weeks. Please visit www.huma.com and follow us on linkedin Huma
Logo – https://mma.prnewswire.com/media/1427908/Huma_Logo.jpg
source huma
